Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
Resistant bacteria are spreading worldwide. In collaboration with partners in India, Tanzania, South Africa and Germany, we have investigated the causes and consequences of this spread.2 This Pharma-Brief Special presents the results. It examines the risks for humans, animals and the environment. It focuses on local problems and approaches, international interactions and the re-sponsibility of doctors, farmers and consumers.
more
Clinician Outreach and Communication Activity (COCA) Call
April 12, 2016
3rd edition!Large File 17 MB!
The official death toll had risen to 493 people as of 29 March, according to the Government.
A new cholera outbreak was reported in Nhamatande; nine Cholera Treatment Centres have been established in Beira and other locations.
More than 140,000 people were displaced in 161 sites across Sofala (116... sites), Manica (27 sites), Zambezia (13 sites) Tete (5 sites); of whom more than 7,400 were identified as vulnerable, according to the Government.
more
This policy brief is targeted at national governments, donors and regional and international actors to support Ebola-affected countries to transition from emergency response to recovery.
Capability and Performance
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7